Product Information
DANTROLENE SODIUM 50 MG CAP is a generic product labeled by Amneal Pharmaceuticals of New York LLC, priced at $0.5538 per EA under NDC 00115442201. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Mar 1, 2005. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
50 mg/1
Manufacturer
Amneal Pharmaceuticals of New York LLCNDC
00115442201
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DANTROLENE SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA076856FDA Approved
3/1/2005
TE Code
AB
On Market Since
3/1/2005
Pharmacological Classes
Price Statistics
The NADAC for DANTROLENE SODIUM 50 MG CAP has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 57.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5538 per EA |
|---|---|
| All-time high | $1.4657 (Jun 15, 2016) |
| All-time low | $0.5225 (Sep 20, 2023) |
| 52-week high | $0.7558 |
| 52-week low | $0.5538 |
| Median price | $1.0470 |
| Average price | $0.9966 |
| Largest weekly change | -35.5% (Sep 20, 2023) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Dantrolene Sodium market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Amneal Pharmaceuticals of New York LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Dantrolene Sodium market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Skeletal Muscle Relaxant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DANTROLENE SODIUM 50 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for DANTROLENE SODIUM 50 MG CAP, manufactured by Amneal Pharmaceuticals of New York LLC, is $0.5538 per EA (NDC 00115442201), effective Sep 30, 2026.
How has the price of DANTROLENE SODIUM 50 MG CAP changed over time?
Over the history we have for it, the NADAC for DANTROLENE SODIUM 50 MG CAP has declined 57.5%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for DANTROLENE SODIUM 50 MG CAP?
Since Nov 28, 2013, the NADAC for DANTROLENE SODIUM 50 MG CAP has ranged from a low of $0.5225 (Sep 20, 2023) to a high of $1.4657 (Jun 15, 2016), with a median of $1.0470 per EA.
Are there cheaper alternatives to DANTROLENE SODIUM 50 MG CAP?
No other NADAC-published product currently shares the active ingredient and strength of DANTROLENE SODIUM 50 MG CAP in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures DANTROLENE SODIUM 50 MG CAP?
DANTROLENE SODIUM 50 MG CAP (NDC 00115442201) is labeled by Amneal Pharmaceuticals of New York LLC, and CMS classifies it as a generic product.